Podcasts

Kevin Williams, MS, MPAS, PA-C shares strategies when switching or reducing antipsychotics isn’t feasible.

Desiree Matthews, PMHNP-BC reviews the AIMS and other assessment instruments—what to use and when.

Desiree Matthews, PMHNP-BC provides a clinical guide to distinguishing these movement disorders.

Desiree Matthews, PMHNP-BC gives a brief, clinical overview of the prevalence, symptoms, and diagnostic criteria for TD. 

Desiree Matthews, PMHNP-BC, discusses what realistic treatment outcomes look like and how to talk about them with patients.

Jonathan Meyer, MD discusses age, sex, duration of treatment, comorbidities, and other risk factors.

Jonathan Meyer, MD discusses subtle movements that are easy to overlook and how to recognize them early.

Jonathan Meyer, MD compares first-generation and second-generation antipsychotics in TD risk.

Dr. Meyer discusses how dopamine receptor changes contribute to the development of tardive dyskinesia and the potentially detrimental effects of some treatments.